Xiaobo Lu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications
Papers in
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
-
- RNA Research and Splicing 2
- Co-authors
- Jie Weng (4 shared papers)Lian Tang (4 shared papers)Ke Duan (3 shared papers)Taijun Chen (2 shared papers)Meiyun Tan (2 shared papers)Jianhua Ge (4 shared papers)Zhong Li (1 shared paper)Ge Chen (1 shared paper)
- Journals
- Journal of Materials Chemistry B (1 paper)Materials Science and Engineering C (1 paper)ACS Biomaterials Science & Engineering (1 paper)Connective Tissue Research (1 paper)Emerging infectious diseases (1 paper)
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Xiaobo Lu
20 papers receiving 483 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 140
- Biomaterials 97
- Molecular Medicine 22
- Rehabilitation 27
- Biomedical Engineering 132
Countries citing papers authored by Xiaobo Lu
This map shows the geographic impact of Xiaobo Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Lu more than expected).
Fields of papers citing papers by Xiaobo Lu
This network shows the impact of papers produced by Xiaobo Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Lu. The network helps show where Xiaobo Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobo Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 72 | |
| 2 | 2017 | 59 | |
| 3 | 2020 | 47 | |
| 4 | 2018 | 45 | |
| 5 | 2018 | 42 | |
| 6 | 2018 | 41 | |
| 7 | 2016 | 34 | |
| 8 | 2017 | 33 | |
| 9 | 2019 | 27 | |
| 10 | MiR-30a attenuates osteoclastogenesis via targeting DC-STAMP-c-Fos-NFATc1 signaling. | 2017 | 26 |
| 11 | 2017 | 15 | |
| 12 | 2020 | 12 | |
| 13 | 2022 | 8 | |
| 14 | IGF-1R promotes the expression of cyclin D1 protein and accelerates the G1/S transition by activating Ras/Raf/MEK/ERK signaling pathway. | 2017 | 6 |
| 15 | 2023 | 5 | |
| 16 | 2018 | 5 | |
| 17 | 2017 | 4 | |
| 18 | 2019 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2025 | 1 |
About Xiaobo Lu
Xiaobo Lu is a scholar working on Cancer Research, Molecular Biology, Biomedical Engineering, Surgery and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 489 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), 3D Printing in Biomedical Research (3 papers), Bone Tissue Engineering Materials (3 papers), Tissue Engineering and Regenerative Medicine (2 papers), Electrospun Nanofibers in Biomedical Applications (2 papers), RNA Research and Splicing (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (140 citations), Biomaterials (97 citations), Molecular Medicine (22 citations), Rehabilitation (27 citations) and Biomedical Engineering (132 citations). Xiaobo Lu has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Jie Weng, Lian Tang, Ke Duan, Taijun Chen, Meiyun Tan, Jianhua Ge, Zhong Li, Ge Chen, Jianxin Wang and Zhong Li. Their work appears in journals such as Journal of Materials Chemistry B, Materials Science and Engineering C, ACS Biomaterials Science & Engineering, Connective Tissue Research and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.